Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

NextCell Pharma AB

NXTCL
Current price
3.32 SEK +0.02 SEK (+0.61%)
Last closed 3.26 SEK
ISIN SE0009723125
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 241 559 865 SEK
Yield for 12 month +37.76 %
1Y
3Y
5Y
10Y
15Y
NXTCL
21.11.2021 - 28.11.2021

NextCell Pharma AB, a biopharmaceutical company, engages in the research, development, and manufacture of novel stromal cell therapies in Sweden. The company develops ProTrans, a drug candidate that consists of stem cells for the treatment of autoimmune disease, including type-1 diabetes. It also operates Cellaviva, a stem cell bank. The company was incorporated in 2014 and is based in Huddinge, Sweden. Address: Karolinska Institutet Science Park, Huddinge, Sweden, 141 57

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

85.22 SEK

P/E ratio

Dividend Yield

Current Year

+10 616 206 SEK

Last Year

+10 067 490 SEK

Current Quarter

+2 815 600 SEK

Last Quarter

+1 635 198 SEK

Current Year

-43 549 208 SEK

Last Year

-880 809 SEK

Current Quarter

+321 260 SEK

Last Quarter

-13 570 956 SEK

Key Figures NXTCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -39 600 374 SEK
Operating Margin TTM -289.17 %
PE Ratio
Return On Assets TTM -34.29 %
PEG Ratio
Return On Equity TTM -64.08 %
Wall Street Target Price 85.22 SEK
Revenue TTM 9 404 937 SEK
Book Value 0.81 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY -39.00 %
Dividend Yield
Gross Profit TTM -5 588 462 SEK
Earnings per share -0.40 SEK
Diluted Eps TTM -0.40 SEK
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics NXTCL

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History NXTCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – SEK
Last Split Factor
Payout Ratio
Last Split Date

Stock Valuation NXTCL

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 22.55
Price Sales TTM 25.68
Enterprise Value EBITDA -1.83
Price Book MRQ 4.07

Financials NXTCL

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators NXTCL

For 52 weeks

1.06 SEK 4.01 SEK
50 Day MA 2.71 SEK
Shares Short Prior Month
200 Day MA 1.87 SEK
Short Ratio
Shares Short
Short Percent